Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study

Authors not listed

IBSA Farmaceutici Italia Srl · 2023

Abstract

Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Anonymous. (2023). Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study. <em>IBSA Farmaceutici Italia Srl</em>. https://clinicaltrials.gov/study/NCT05936346
Vancouver
Anonymous. Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study. IBSA Farmaceutici Italia Srl. 2023.
BibTeX
@misc{anon2023Evalua, title = {Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient in a Healthy Population: a Randomized, Open Label, Parallel-arm, Two-dose Study}, author = {Anonymous}, journal = {IBSA Farmaceutici Italia Srl}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings